BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 1534650)

  • 1. Abnormal serum IgG subclass pattern in children with Down's syndrome.
    Annerén G; Magnusson CG; Lilja G; Nordvall SL
    Arch Dis Child; 1992 May; 67(5):628-31. PubMed ID: 1534650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome.
    Loh RK; Harth SC; Thong YH; Ferrante A
    Pediatr Infect Dis J; 1990 Aug; 9(8):547-51. PubMed ID: 2146585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in serum concentrations of IgG2 and IgG4 by selenium supplementation in children with Down's syndrome.
    Annerén G; Magnusson CG; Nordvall SL
    Arch Dis Child; 1990 Dec; 65(12):1353-5. PubMed ID: 2148668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal serum immunoglobulin levels in Down's syndrome patients.
    Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
    Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome.
    Singh VK; Fudenberg HH
    Autoimmunity; 1989; 3(2):95-101. PubMed ID: 2535254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunoglobulin G subclasses in children infected with human immunodeficiency virus type 1.
    Roilides E; Black C; Reimer C; Rubin M; Venzon D; Pizzo PA
    Pediatr Infect Dis J; 1991 Feb; 10(2):134-9. PubMed ID: 2062605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down's syndrome is a risk factor for severe lower respiratory tract infection due to respiratory syncytial virus.
    Galleguillos C; Galleguillos B; Larios G; Menchaca G; Bont L; Castro-Rodriguez JA
    Acta Paediatr; 2016 Nov; 105(11):e531-e535. PubMed ID: 27537430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children.
    Burgio GR; Lanzavecchia A; Maccario R; Vitiello A; Plebani A; Ugazio AG
    Clin Exp Immunol; 1978 Aug; 33(2):298-301. PubMed ID: 152683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoglobulin and lysozyme concentration in the serum of patients with Down's syndrome].
    Shvarts EI; Ostrovskiĭ AD; Zefirov IuN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1427-30. PubMed ID: 158927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between dental caries in the primary dentition and anti S. mutans serum antibodies in children with Down's syndrome.
    Morinushi T; Lopatin DE; Tanaka H
    J Clin Pediatr Dent; 1995; 19(4):279-84. PubMed ID: 7547486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T and B lymphocytes in patients with Down's syndrome.
    Reiser K; Whitcomb C; Robinson K; MacKenzie MR
    Am J Ment Defic; 1976 May; 80(6):613-9. PubMed ID: 134638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective monocyte chemotaxis in children with Down's syndrome.
    Barroeta O; Nungaray L; López-Osuna M; Armendares S; Salamanca F; Kretschmer RR
    Pediatr Res; 1983 Apr; 17(4):292-5. PubMed ID: 6222283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome of acute myeloid leukaemia in Down's syndrome.
    Craze JL; Harrison G; Wheatley K; Hann IM; Chessells JM
    Arch Dis Child; 1999 Jul; 81(1):32-7. PubMed ID: 10373130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
    Bartelik S
    Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megakaryoblastic leukemia and Down's syndrome: a review.
    Zipursky A; Peeters M; Poon A
    Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of coeliac disease in Down's syndrome in Malta.
    Sciberras C; Vella C; Grech V
    Ann Trop Paediatr; 2004 Mar; 24(1):81-3. PubMed ID: 15005971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic parameters in Down's syndrome.
    Jacobs PF; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different visual development: norms for visual acuity in children with Down's syndrome.
    Zahidi AA; Vinuela-Navarro V; Woodhouse JM
    Clin Exp Optom; 2018 Jul; 101(4):535-540. PubMed ID: 29601092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.